| NCT ID | NCT03268057 |
| Title | VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | yes |
| Sponsors | Vaccinex Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior adult |